The Role of the Gut Microbiome in Resisting Norovirus Infection as Revealed by a Human Challenge Study

Details

• Alternative Title:
  mBio
• Personal Author:
  Patin, N. V. ; Peña-Gonzalez, A. ; Hatt, J. K. ; Moe, C. ; Kirby, A. ; Konstantinidis, K. T.
• Description:
  Norovirus infections take a heavy toll on worldwide public health. While progress has been made toward understanding host responses to infection, the role of the gut microbiome in determining infection outcome is unknown. Moreover, data are lacking on the nature and duration of the microbiome response to norovirus infection, which has important implications for diagnostics and host recovery. Here, we characterized the gut microbiomes of subjects enrolled in a norovirus challenge study. We analyzed microbiome features of asymptomatic and symptomatic individuals at the genome (population) and gene levels and assessed their response over time in symptomatic individuals. We show that the preinfection microbiomes of subjects with asymptomatic infections were enriched in | and depleted in | relative to the microbiomes of symptomatic subjects. These compositional differences were accompanied by differences in genes involved in the metabolism of glycans and sphingolipids that may aid in host resilience to infection. We further show that microbiomes shifted in composition following infection and that recovery times were variable among human hosts. In particular, | increased immediately following the challenge, while | and | decreased over the same time. Genes enriched in the microbiomes of symptomatic subjects, including the adenylyltransferase |, were linked to glycan metabolism and cell-cell signaling, suggesting as-yet unknown roles for these processes in determining infection outcome. These results provide important context for understanding the gut microbiome role in host susceptibility to symptomatic norovirus infection and long-term health outcomes.| The role of the human gut microbiome in determining whether an individual infected with norovirus will be symptomatic is poorly understood. This study provides important data on microbes that distinguish asymptomatic from symptomatic microbiomes and links these features to infection responses in a human challenge study. The results have implications for understanding resistance to and treatment of norovirus infections.
• Subjects:
  Asymptomatic Diseases Bacteroidetes Caliciviridae Infections Disease Susceptibility Firmicutes Gastrointestinal Microbiome Host-Microbe Biology Human Microbiome Humans Metagenomics Norovirus Noroviruses Proteobacteria Research Article

  More +
• Source:
  mBio. 2020; 11(6)
• Pubmed ID:
  33203758
• Pubmed Central ID:
  PMC7683401
• Document Type:
  Journal Article
• Funding:
  K01 AI103544/AI/NIAID NIH HHSUnited States/ ; R01 AI137679/AI/NIAID NIH HHSUnited States/
• Volume:
  11
• Issue:
  6
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha256:ef740d81e55198ff84d8d35875e34b3d744241efa2bada1c4e853036843029fd
• Download URL:
  https://stacks.cdc.gov/view/cdc/111656/cdc_111656_DS1.pdf
• File Type:
  [PDF - 2.45 MB ]